Patents by Inventor Walid Kamoun

Walid Kamoun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nanoliposomal Targeting of Ephrin Receptor A2 (Epha2) and Related Diagnostics
    Publication number: 20190298681
    Abstract: EphA2 targeted doxorubicin generating nano-liposomes are useful in the treatment of EphA2 positive cancer comprising cancer cells expressing over about 3000 EphA2 receptors/cell. Diagnostic methods for identifying EphA2 positive cancer patients and methods of treating identified patients with a Eph-A2 targeted nanoliposome encapsulating a docetaxel prodrug are provided.
    Type: Application
    Filed: March 16, 2017
    Publication date: October 3, 2019
    Inventors: Daryl C. Drummond, Dmitri B. Kirpotin, Walid Kamoun
  • Treating Ephrin Receptor A2 (Epha2) Positive Cancer with Targeted Docetaxel-Generating Nano-Liposome Compositions
    Publication number: 20190070113
    Abstract: EphA2 targeted doxorubicin generating nano-liposomes are useful in the treatment of cancer overexpressing EphA2, alone or in combination with chemotherapeutic agents such as gemcitabine or carboplatin.
    Type: Application
    Filed: March 16, 2017
    Publication date: March 7, 2019
    Applicant: Merrimack Pharmaceuticals, Inc.
    Inventors: Daryl C. Drummond, Walid Kamoun
  • Non-Invasive Imaging Methods for Patient Selection for Treatment with Nanoparticulate Therapeutic Agents
    Publication number: 20170340656
    Abstract: Methods for providing treatment of pathologic conditions with nanoparticulate therapeutic agents are disclosed. Novel methods for determining liposomal deposition at sites of pathology using non-invasive imaging are also disclosed.
    Type: Application
    Filed: June 14, 2017
    Publication date: November 30, 2017
    Inventors: Daryl C. Drummond, Jonathan B. Fitzgerald, Ashish KaIra, Walid Kamoun, Stephan Klinz
  • METHODS AND COMPOSITIONS FOR IMPROVING OUTCOMES OF LIPOSOMAL CHEMOTHERAPY
    Publication number: 20170231911
    Abstract: Materials and methods for treating cancer patients with immunoliposomal chemotherapeutic agents are disclosed. The methods comprise administering to a patient a therapeutically effective amount of an immunoliposome in combination with a chemotherapeutic agent comprising an alkylating agent or an organoplatinum agent. The materials are immunoliposomal chemotherapeutic agents and chemotherapeutic preparations comprising an alkylating agent or an organoplatinum agent, each for use in the disclosed methods.
    Type: Application
    Filed: November 21, 2016
    Publication date: August 17, 2017
    Inventors: Elena GERETTI, Bart S. HENDRIKS, Victor MOYO, Thomas WICKHAM, Daryl C. DRUMMOND, Dmitri KIRPOTIN, Walid KAMOUN
  • METHODS AND COMPOSITIONS FOR IMPROVING OUTCOMES OF LIPOSOMAL CHEMOTHERAPY
    Publication number: 20160184227
    Abstract: Materials and methods for treating cancer patients with immunoliposomal chemotherapeutic agents are disclosed. The methods comprise administering to a patient a therapeutically effective amount of an immunoliposome in combination with a chemotherapeutic agent comprising an alkylating agent or an organoplatinum agent. The materials are immunoliposomal chemotherapeutic agents and chemotherapeutic preparations comprising an alkylating agent or an organoplatinum agent, each for use in the disclosed methods.
    Type: Application
    Filed: December 3, 2015
    Publication date: June 30, 2016
    Inventors: ELENA GERETTI, BART S. HENDRIKS, VICTOR MOYO, THOMAS WICKHAM, DARYL C. DRUMMOND, DMITRI D. KIRPOTIN, WALID KAMOUN
  • METHODS AND COMPOSITIONS FOR IMPROVING OUTCOMES OF LIPOSOMAL CHEMOTHERAPY
    Publication number: 20160067182
    Abstract: Materials and methods for treating cancer patients with immunoliposomal chemotherapeutic agents are disclosed. The methods comprise administering to a patient a therapeutically effective amount of an immunoliposome in combination with a chemotherapeutic agent comprising an alkylating agent or an organoplatinum agent. The materials are immunoliposomal chemotherapeutic agents and chemotherapeutic preparations comprising an alkylating agent or an organoplatinum agent, each for use in the disclosed methods.
    Type: Application
    Filed: April 9, 2014
    Publication date: March 10, 2016
    Inventors: ELENA GERETTI, BART S. HENDRIKS, VICTOR MOYO, THOMAS WICKHAM, DARYL C. DRUMMOND, DMITRI KIRPOTIN, WALID KAMOUN
  • NON-INVASIVE IMAGING METHODS FOR PATIENT SELECTION FOR TREATMENT WITH NANOPARTICULATE THERAPEUTIC AGENTS
    Publication number: 20140170075
    Abstract: Methods for providing treatment of pathologic conditions with nanoparticulate therapeutic agents are disclosed. Novel methods for determining liposomal deposition at sites of pathology using non-invasive imaging are also disclosed.
    Type: Application
    Filed: February 14, 2014
    Publication date: June 19, 2014
    Inventors: Daryl C. Drummond, Jonathan B. Fitzgerald, Ashish Kalra, Walid Kamoun, Stephan Klinz